JEFFREY FEINSTEIN, M.D.
Rheumatology Physician · WINDCREST, TX
Individual Active NPI 1609867241
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 572 | 246,562 | $6,590,216 | $3,248,050 | $2,560,673 |
| 2023 | 550 | 222,012 | $5,524,360 | $2,744,745 | $2,164,015 |
| 2022 | 569 | 190,996 | $4,527,877 | $2,649,777 | $2,094,723 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 138,800 | $5 | $4 |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 24,975 | $43 | $34 |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 19,600 | $12 | $9 |
| J0897 | Injection, denosumab, 1 mg | 7,500 | $26 | $20 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 5,800 | $0 | $0 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3,990 | $31 | $25 |
| J7318 | Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 1,920 | $7 | $5 |
| J7322 | Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 1,896 | $17 | $14 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 1,411 | $17 | $13 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 1,391 | $127 | $92 |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | 928 | $17 | $13 |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 770 | $70 | $56 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Rheumatology Physician | 207RR0500X | ✓ | M2320 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Rheumatology Physician providers in Texas
- NPI 1891014205
- NPI 1003058934
- NPI 1912294976
- NPI 1316935836
- NPI 1346747086
- NPI 1154522795
- NPI 1043280381
- NPI 1114689460
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.